Nova Patents
LTIP495A

O-heyteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides

Abstract

O- heteroaryl-, O alkylheteroaryl-. O-alkenylheteroaryl- and O-alkynylheteroarylmacrolides, in joint formula:<IMAGE>that are synthesized from respective original agents through alkylation and/or arylation cyclohexyl ring C-3'' and/or C-4'' atoms. These macrolide immunosuppressive is useful in mammal treatment in case of autoimmune diseases, infections and in the prevention of transplanted organ rejection and/or in the treatment of similar disorders, diseases and illnesses.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

31 members in 23 offices

This recordMember, by publication datePriority claim13 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
75694691United States of AmericaA
756946–––
US19910756946–––

Members31

Family members, oldest first
DocumentOfficeKind
IL103009D0IsraelD0
CA2077331A1CanadaA1
AU2282992AAustraliaA
EP0532088A1European Patent Office (EPO)A1
WO9305058A1World Intellectual Property Organization (WIPO)A1
MX9205137AMexicoA
KR930006030ARepublic of KoreaA
ZA926812BSouth AfricaB
CN1073443AChinaA
US5252732AUnited States of AmericaA
NO940805D0NorwayD0
AU647665B2AustraliaB2
JPH06116274AJapanA
FI941085AFinlandA
NO940805LNorwayL
HU9400686D0HungaryD0
SK26094A3SlovakiaA3
CZ53194A3CzechiaA3
US5349061AUnited States of AmericaA
LTIP495AThis recordLithuaniaA
HUT66855AHungaryA
BG98639ABulgariaA
NZ244153ANew ZealandA
LT3533BLithuaniaB
YU89792AYugoslavia, later Serbia and Montenegro (until 2006)A
JPH0813819B2JapanB2
EP0532088B1European Patent Office (EPO)B1
AT145915TAustriaT
DE69215615D1GermanyD1
DE69215615T2GermanyT2
RO114331B1RomaniaB1